XML 42 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements
3 Months Ended
Mar. 31, 2014
Fair Value Measurements [Abstract]  
Fair Value Measurements
6.  Fair Value Measurements

We record auction rate securities at fair value in the accompanying Consolidated Balance Sheets in accordance with ASC 320 Investments – Debt and Equity Securities. The change in the fair value of these investments is recorded as a component of other comprehensive loss (see Note 3. Summary of Significant Accounting Policies - Fair Value Measurements in the notes to consolidated financial statements included in our 2013 Annual Report on Form 10-K). We also record the contingent consideration liability resulting from the MIP acquisition at fair value in accordance with ASC 820-10-50.

The following tables present our money market funds and auction rate securities and contingent consideration liability measured at fair value on a recurring basis as of the dates indicated, classified by valuation hierarchy:

 
 
  
Fair Value Measurements at March 31, 2014
 
 
Balance at
March 31, 2014
  
Quoted Prices in Active Markets for Identical Assets
(Level 1)
  
Significant Other Observable Inputs
(Level 2)
  
Significant Unobservable Inputs
(Level 3)
Assets:
 
  
  
  
Money market funds
 
$
85,373
  
$
85,373
  
$
-
  
$
-
Auction rate securities
  
2,208
   
-
   
-
   
2,208
Total Assets
 
$
87,581
  
$
85,373
  
$
-
  
$
2,208
 
               
Liability:
               
Contingent consideration
 
$
16,200
  
$
-
  
$
-
  
$
16,200
Total Liability
 
$
16,200
  
$
-
  
$
-
  
$
16,200

 
 
  
Fair Value Measurements at December 31, 2013
 
 
Balance at
December 31, 2013
  
Quoted Prices in Active Markets for Identical Assets
(Level 1)
  
Significant Other Observable Inputs
(Level 2)
  
Significant Unobservable Inputs
(Level 3)
Assets:
 
  
  
  
Money market funds
 
$
60,364
  
$
60,364
  
$
-
  
$
-
Auction rate securities
  
2,208
   
-
   
-
   
2,208
Total Assets
 
$
62,572
  
$
60,364
  
$
-
  
$
2,208
 
               
Liability:
               
Contingent consideration
 
$
15,700
  
$
-
  
$
-
  
$
15,700
Total Liability
 
$
15,700
  
$
-
  
$
-
  
$
15,700

At March 31, 2014 we held $2,208 in auction rate securities which are classified as Level 3. The fair value of these securities includes U.S. government subsidized securities collateralized by student loan obligations, with maturities greater than 10 years. We will not realize cash in respect of the principal amount of these securities until the issuer calls or restructures the security, the security reaches any scheduled maturity and is paid, or a buyer outside the auction process emerges. We have to date received all scheduled interest payments on these securities, which, in the event of auction failure, are reset according to contractual terms in the governing instruments.

The valuation of auction rate securities we hold is based on Level 3 unobservable inputs which consist of our internal analysis of (i) timing of expected future successful auctions or issuer calls of the securities, (ii) collateralization of underlying assets of the security and (iii) credit quality of the security. Significant increases or decreases in the redemption period or discount rates would result in a significantly lower or higher, respectively, fair value measurement. The temporary impairment amount associated with these securities, the duration of which is greater than 12 months, remained unchanged from year-end 2013 at $192, which is reflected as part of accumulated other comprehensive loss on our accompanying Consolidated Balance Sheets. Based on our re-evaluation for this quarter, we continue to believe that we have the ability to hold these securities until recovery of fair value. Due to the uncertainty related to the liquidity in the auction rate security market and therefore when individual positions may be liquidated, we have classified these auction rate securities as long-term assets on our accompanying Consolidated Balance Sheets. We continue to monitor markets for our investments and consider the impact, if any, of market conditions on the fair market value of our investments. We do not believe the carrying values of our investments are other than temporarily impaired and therefore expect the positions will eventually be liquidated without significant loss.

The estimated fair value of the contingent consideration liability of $16.2 million as of March 31, 2014, represents future potential milestone payments to former MIP stockholders. The Company considers this liability a Level 3 instrument (one with significant unobservable inputs) in the fair value hierarchy. The estimated fair value was determined based on probability adjusted discounted cash flow and Monte Carlo simulation models that included significant estimates and assumptions pertaining to commercialization events and sales targets. The most significant unobservable inputs were the probabilities of achieving regulatory approval of the development projects and subsequent commercial success, and discount rates. Significant changes in any of the probabilities of success would result in a significantly higher or lower fair value measurement, respectively. Significant changes in the probabilities as to the periods in which milestones will be achieved would result in a significantly lower or higher fair value measurement, respectively. The Company records the contingent consideration liability at fair value with changes in estimated fair values recorded in general and administrative expenses in the Consolidated Statements of Operations.

The following table presents quantitative information pertaining to the March 31, 2014 fair value measurement of the Level 3 inputs. The assumptions remained unchanged since December 31, 2013:

 
Fair Value as
of March 31,
2014
 
Fair Value as of December 31,
2013
 
Valuation Technique
Unobservable Input
 
Range
(Weighted Average)
 
 
 
 
 
 
Asset:
 
 
 
 
 
Auction rate securities
$
2,208
 
$
2,208
 
Discounted cash flow model
Redemption period
 
5 to 15 years
(6 years)
 
      
    
Discount rate
 
0.25% - 3.00% (1.55%)
Contingent consideration
liability:
      
 
 
  
Azedra commercialization
$
2,300
 
$
2,300
 
Probability adjusted discounted cash flow model
Probability of success
 
40%
 
      
    
Period of milestone expected achievement
 
2017
 
      
    
Discount rate
 
10%
 
      
 
 
  
1404 commercialization
$
2,100
 
$
2,000
 
Probability adjusted discounted cash flow model
Probability of success
 
31%
 
      
    
Period of milestone expected achievement
 
2018
 
      
    
Discount rate
 
10%
 
      
 
 
  
MIP-1095 commercialization
$
500
 
$
500
 
Probability adjusted discounted cash flow model
Probability of success
 
19%
 
      
    
Period of milestone expected achievement
 
2021
 
      
    
Discount rate
 
10%
 
      
 
 
  
Net sales targets
$
11,300
 
$
10,900
 
Monte-Carlo simulation
Probability of success
 
19% - 40%
(32.8%)
 
      
    
Period of milestone expected achievement
 
2018 - 2022
 
      
    
Discount rate
 
12.5%

For those financial instruments with significant Level 3 inputs, the following table summarizes the activities for the periods indicated:

 
 
Asset – Auction Rate Securities
Fair Value Measurements Using Significant
Unobservable Inputs
(Level 3)
For the Three Months Ended March 31,
 
Description
 
2014
  
2013
 
Balance at beginning of period
 
$
2,208
  
$
3,240
 
Transfers into Level 3
  
-
   
-
 
Total realized/unrealized gains (losses)
        
Included in net income (loss)
  
-
   
-
 
Included in comprehensive income (loss)
  
-
   
8
 
Settlements
  
-
   
(100
)
Balance at end of period
 
$
2,208
  
$
3,148
 
  Total amount of unrealized gains (losses) for the period included in other comprehensive loss attributable to the change in fair market value of related assets still held at the reporting date
 
$
-
  
$
-
 

 
 
Liability – Contingent Consideration
Fair Value Measurements Using Significant
Unobservable Inputs
(Level 3)
For the Three Months Ended March 31,
 
Description
 
2014
  
2013
 
Balance at beginning of period
 
$
15,700
  
$
-
 
Fair value of contingent consideration – acquisition of Molecular Insight
  
-
   
15,900
 
Fair value change to contingent consideration included in net loss
  
500
   
-
 
Balance at end of period
 
$
16,200
  
$
15,900
 
  Changes in unrealized gains or losses for the period included in earnings (or changes in net assets) for liabilities held at the end of the reporting period
 
$
500
  
$
-